| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.89.json | Interventions Related to Care Coordination, Referrals for Specific Services | active | | | 2023-12 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.9.json | Reasons for Interventions Related to Medication Management, Dose Too High | active | | | 2019-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.90.json | Recommendations Related to Medication Regimen, Continue Medication | active | | | 2017-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.91.json | Recommendations Related to Medication Regimen, Initiate Medication | active | | | 2017-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.92.json | Recommendations Related to Medication Regimen, Change Medication | active | | | 2021-03 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.93.json | Recommendations Related to Medication Regimen, Change Medication Dose | active | | | 2017-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.94.json | Recommendations Related to Medication Regimen, Change Medication Dosage Form | active | | | 2017-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.95.json | Recommendations Related to Medication Regimen, Change Medication Course | active | | | 2017-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.97.json | Recommendations Related to Medication Regimen, Change Medication Dosing Interval | active | | | 2017-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.98.json | Recommendations Related to Medication Regimen, Discontinue Medication | active | | | 2017-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1096.99.json | Recommendations Related to Medication Regimen, Monitoring | active | | | 2021-03 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.12.json | Medication Route | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.24.json | Extended Pregnancy Status | active | | | 2023-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.33.json | External Cause of Injury/Morbidity | active | | | 2025-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.35.json | Arthritis Feedback Types (SNOMED) | active | | | 2019-12 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.36.json | Arthritis Feedback Types (LOINC) | active | | | 2025-05 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.45.json | Bidirectional Services eReferral Type | active | | | 2025-05 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.46.json | Bidirectional Services eReferral Reason | active | | | 2025-05 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.50.json | Transport vehicle type | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.54.json | Specimen type | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.55.json | At Home In Vitro Patient Questions | active | | | 2024-08 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1099.58.json | Acute COVID 19 Diagnosis | active | | | 2023-07 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1102.1.json | Case Management for Behavioral Health | active | | | 2021-12 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1102.63.json | Case Management for Behavioral Health | active | | | 2021-12 | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1102.64.json | Case Management for Behavioral Health | active | | | 2021-12 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.124.json | Follow Up Within 6 Months | active | | | 2024-01 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.125.json | Follow Up Within 6 Months | active | | | 2024-01 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.126.json | Bone Scan | active | | | 2024-01 | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.127.json | Bone Scan | active | | | 2024-01 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.15.json | Hospice Care Ambulatory | active | | | 2024-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.175.json | Office and Wellness Visits for General Screening | active | | | 2024-08 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.176.json | Office and Wellness Visits for General Screening | active | | | 2024-08 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.177.json | Office and Wellness Visits for General Screening | active | | | 2024-08 | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.178.json | Office and Wellness Visits for General Screening | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.28.json | Non Acute Encounter Codes CPT | active | | | 2024-06 | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.29.json | Non Acute Encounter Codes HCPCS | active | | | 2024-06 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.31.json | Bleeding Event Diagnosis Codes ICD9 | active | | | 2024-06 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.78.json | Statin Associated Muscle Symptoms | active | | | 2021-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.84.json | Statin Associated Muscle Symptoms | active | | | 2024-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.85.json | Statin Associated Muscle Symptoms | active | | | 2024-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1108.99.json | Underweight | active | | | 2022-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.11.json | Cornual Ectopic Pregnancy | active | | | 2021-06 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.12.json | Cornual Ectopic Pregnancy | active | | | 2021-06 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.13.json | Perforation of Uterus | active | | | 2021-06 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.14.json | Perforation of Uterus | active | | | 2021-06 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.15.json | Uterine Rupture | active | | | 2021-06 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.16.json | Uterine Rupture | active | | | 2021-06 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.17.json | Transabdominal Cerclage | active | | | 2021-06 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.18.json | Transabdominal Cerclage | active | | | 2022-03 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.2.json | Transabdominal Cerclage | active | | | 2021-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.21.json | Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrival | active | | | 2021-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.23.json | Intensive Care Unit | active | | | 2021-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.24.json | Uterine Horn | active | | | 2021-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.25.json | Metroplasty | active | | | 2021-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.3.json | Medical Induction of Labor | active | | | 2021-06 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.35.json | Placenta Previa | active | | | 2021-06 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.36.json | Placenta Accreta Spectrum Previa or Vasa Previa | active | | | 2024-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.37.json | Placenta Accreta Spectrum Previa or Vasa Previa | active | | | 2023-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.38.json | Outpatient Surgery Service | active | | | 2019-04 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.41.json | Statin Allergen | active | | | 2022-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.42.json | Statin Allergen | active | | | 2021-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.50.json | Rivaroxaban for VTE Prophylaxis | active | | | 2022-02 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.51.json | Prasugrel | active | | | 2021-02 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.52.json | Pharmacological Contraindications For Antithrombotic Therapy | active | | | 2022-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.53.json | Acute Renal Failure | active | | | 2024-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.54.json | Total Parenteral Nutrition | active | | | 2021-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.55.json | Intravenous Thrombolytic tPA Therapy | active | | | 2021-02 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.56.json | Intraarterial Thrombolytic tPA Therapy | active | | | 2021-02 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.57.json | Ischemic Stroke Thrombosis | active | | | 2021-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.58.json | Ischemic Stroke Thrombosis | active | | | 2021-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.59.json | Ischemic Stroke Other | active | | | 2021-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.60.json | Ischemic Stroke Other | active | | | 2021-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.61.json | Antithrombotic Therapy Antiplatelet | active | | | 2025-02 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.62.json | Antithrombotic Therapy for Ischemic Stroke | active | | | 2021-04 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.63.json | Present On Admission is Yes or Exempt | active | | | 2022-01 | hl7 | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.64.json | Application of Venous Foot Pumps | active | | | 2022-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.65.json | Application of Intermittent Pneumatic Compression Devices | active | | | 2022-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.66.json | Application of Graduated Compression Stockings | active | | | 2022-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.67.json | 20 to 42 Plus Weeks Gestation | active | | | 2023-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.68.json | 37 to 42 Plus Weeks Gestation | active | | | 2023-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.69.json | 37 to 38 Weeks Gestation | active | | | 2023-03 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.70.json | 20 to 42 Plus Weeks Gestation | active | | | 2023-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.71.json | 20 to 42 Plus Weeks Gestation | active | | | 2025-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.72.json | 37 to 42 Plus Weeks Gestation | active | | | 2023-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.73.json | 37 to 42 Plus Weeks Gestation | active | | | 2023-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.74.json | 37 to 38 Weeks Gestation | active | | | 2023-03 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.75.json | 37 to 38 Weeks Gestation | active | | | 2023-03 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.76.json | History of Atrial Ablation | active | | | 2022-11 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.77.json | Placenta Accreta Spectrum Previa or Vasa Previa | active | | | 2024-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1110.78.json | Placenta Previa | active | | | 2023-11 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.143.json | Observation Services | active | | | 2021-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.159.json | All Primary and Secondary Cancer | active | | | 2023-03 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.161.json | All Primary and Secondary Cancer | active | | | 2022-03 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.163.json | Emergency Department Evaluation | active | | | 2020-03 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.164.json | Admit Inpatient | active | | | 2021-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.171.json | Opioid Use Disorder | active | | | 2024-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.173.json | Sickle Cell Disease with and without Crisis SNOMED | active | | | 2024-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.174.json | Sickle Cell Disease with and without Crisis ICD | active | | | 2024-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.175.json | Sickle Cell Disease with and without Crisis | active | | | 2024-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.176.json | Opioid Medication Assisted Treatment (MAT) HCPCS | active | | | 2024-02 | hl7 | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.177.json | Opioid Medication Assisted Treatment (MAT) | active | | | 2025-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.178.json | Cancer Related Pain ICD 10 | active | | | 2024-02 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.179.json | Cancer Related Pain SNOMED | active | | | 2024-02 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1111.180.json | Cancer Related Pain | active | | | 2024-02 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.10.json | Care Experience Preferences at End of Life LOINC | active | | | 2024-02 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.12.json | Healthcare Agent Ordinality | active | | | 2020-12 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.14.json | ADIClauseTypeVS | active | | | 2022-08 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.17.json | Preconditions for Treatment Preferences | active | | | 2024-03 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.22.json | Advance Directive Document Types | active | | | 2024-07 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.23.json | AD Conditions and Prognosis Scenarios | active | | | 2023-08 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.26.json | Healthcare Agent or Advisor Indicator | active | | | 2024-03 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.27.json | Initial Treatment portable medical order options | active | | | 2024-08 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.28.json | Cardiopulmonary Resuscitation Order Options | active | | | 2024-09 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.30.json | Cardiopulmonary Resuscitation Order Procedures | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.31.json | Cardiopulmonary Resuscitation Procedures Grouping | active | | | 2024-09 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.32.json | Additional Portable Medical Order Procedures | active | | | 2025-04 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.33.json | Initial Treatment Portable Medical Order Procedures Grouping | active | | | 2024-09 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.34.json | Additional portable medical order Procedures Grouping | active | | | 2024-09 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.35.json | Medically Assisted Nutrition Order Options | active | | | 2024-09 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.36.json | Medically Assisted Nutrition Portable Medical Order Procedures Grouping | active | | | 2024-09 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.37.json | Healthcare Agent Powers | active | | | 2024-11 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.38.json | Personal Health Goal Options LOINC | active | | | 2025-03 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.40.json | Portable Medical Order Document Types | active | | | 2025-04 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.41.json | Advance Healthcare Directive Document Types Grouper | active | | | 2025-04 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1115.8.json | Treatment Intervention Preferences at End of Life LOINC | active | | | 2025-04 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.1.json | Rituximab Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.100.json | Pathological M Stage M1c | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.101.json | Pathological N Stage N3 | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.102.json | N Stage pN1a | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.103.json | N Stage pN1b | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.105.json | Pathological N Stage pN1mi | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.106.json | Pathological N Stage N2b | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.107.json | Pathological N Stage N2a | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.108.json | Pathological N Stage N2 | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.109.json | Pathological N Stage N1b | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.110.json | Pathological N Stage N1a | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.112.json | Pathological N Stage N0 | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.114.json | Pathological T Stage T4d | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.115.json | Pathological T Stage T4c | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.116.json | Pathological T Stage T4b | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.117.json | Pathological T Stage T4a | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.118.json | Pathological T Stage T4 | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.120.json | N Stage N2C | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.121.json | T Stage T3c | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.122.json | T Stage T3b | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.123.json | T Stage T3a | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.124.json | Pathological T Stage T3 | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.125.json | T Stage T2c | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.126.json | T Stage T2b | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.127.json | T Stage T2a | active | | | 2024-06 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.128.json | Pathological T Stage T2 | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.129.json | Pathological T Stage T1c | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.132.json | Pathological T Stage T1b | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.135.json | Pathological T Stage T1a | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.136.json | Pathological T Stage T1 | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.137.json | Pathological T Stage T1mic | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.139.json | Pathological T Stage T0 | active | | | 2024-08 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.142.json | Cancer Stage III | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.143.json | Cancer Stage IIIA | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.144.json | Cancer Stage IIIB | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.145.json | Cancer Stage IIIC | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.146.json | Cancer Stage IV | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.147.json | Cancer Stage IVA | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.148.json | Cancer Stage IVB | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.149.json | Cancer Stage IVC | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.151.json | Cisplatin Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.153.json | Vinorelbine Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.154.json | Gemcitabine Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.155.json | Docetaxel | active | | | 2024-09 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.156.json | Pemetrexed Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.158.json | Vinblastine Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.160.json | ECOG Performance Status | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.161.json | ECOG Performance Status | active | | | 2020-10 | hl7 | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.162.json | ECOG Performance Status | active | | | 2022-03 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.164.json | Karnofsky Performance Status | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.165.json | Carboplatin Injectable | active | | | 2020-09 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.166.json | Paclitaxel | active | | | 2024-09 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.168.json | Doxorubicin Injectable | active | | | 2022-09 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.169.json | Irinotecan Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.179.json | Bevacizumab Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.181.json | Methotrexate | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.184.json | Breast Cancer | active | | | 2022-06 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.185.json | Breast Cancer | active | | | 2023-07 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.191.json | Cancer Stage II | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.192.json | Cancer Stage IIA | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.193.json | Cancer Stage IIB | active | | | 2024-07 | hl7 | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.194.json | Pertuzumab Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.196.json | Ixabepilone Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.197.json | Goserelin | active | | | 2024-09 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.200.json | Epirubicin Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.202.json | Ramucirumab Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.204.json | Letrozole | active | | | 2024-09 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.206.json | Exemestane | active | | | 2024-09 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.209.json | Fluorouracil | active | | | 2024-09 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.210.json | Capecitabine Oral | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.222.json | Aprepitant Oral | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.223.json | Fosaprepitant Injectable | active | | | 2024-12 | hl7 | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.255.json | Colorectal Cancer | active | | | 2021-12 | hl7 | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.256.json | Colorectal Cancer | active | | | 2021-12 | hl7 | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1116.257.json | Colorectal Cancer Chemotherapy | active | | | 2023-12 | hl7 | rx |